March 7, 2024

Profound Research: Spotlight on Faisal Musa, M.D., Medical Oncologist

At Profound Research, we strive to highlight the remarkable individuals who contribute to the advancement of medical science and patient care through clinical research. Today, we have the privilege of sharing insights from Faisal Musa, M.D., a Medical Oncologist and Profound Research Principal Investigator at Michigan Healthcare Professionals (MHP) located in Dearborn. Let's delve into Dr. Musa's journey in clinical research, his insights, and his contributions to the field.

What led you to clinical research?

Oncology is a dynamic and ever-evolving field that presents continuous challenges. My passion for making a meaningful difference in patients' lives, coupled with the opportunity to explore novel treatments and therapies, drew me towards clinical research. Being at the forefront of discovering new ways to combat cancer and improve outcomes for patients is immensely fulfilling.

What is your favorite part about working in clinical research?

One of the most exhilarating aspects of clinical research is the opportunity to venture into the unknown. Exploring the efficacy and potential side effects of new medications and treatments not only expands our understanding but also holds the promise of revolutionizing patient care. Additionally, being involved in pioneering therapies that could shape the future of medicine is truly rewarding.

Do you have a particular success story that stuck with you?

Indeed, I have a memorable success story involving a Multiple Myeloma patient who has been on Revlimid successfully for over 10 years, with stable disease. Witnessing the tangible impact of innovative treatments on patients' lives reaffirms the importance of clinical research and motivates me to continue pushing boundaries in oncology.

What would you want people to know about clinical research?

It's crucial for individuals to understand that while clinical trials may not offer immediate solutions for every condition, they play an indispensable role in advancing medical knowledge and developing new therapies. By participating in clinical trials, patients not only contribute to the collective effort in finding better treatments but also gain access to potentially groundbreaking interventions.

What are some hobbies/interests of yours outside of clinical research?

Outside of my professional endeavors, I am an avid soccer enthusiast. Engaging in sports not only provides a welcome respite from the demands of clinical research but also promotes physical well-being and a balanced lifestyle.

Is there any other information you’d like sponsors or patients to know about you?

As a community hematologist and oncologist, I am committed to providing comprehensive care across a wide spectrum of hematological disorders and solid tumors. Additionally, serving as a System Professor at Wayne State University and holding the position of Section Chief of Medical Oncology at Corewell Health System in Dearborn underscores my dedication to academic excellence and clinical leadership.

In Closing

The expertise, dedication, and groundbreaking research of Dr. Musa have not only elevated the field of medical oncology but have also touched the lives of countless patients. His insights shed light on the transformative potential of clinical trials and the profound impact they can have on individuals battling cancer.

As we conclude this spotlight, we are reminded of the profound impact that passionate individuals can have on our collective well-being. We encourage you to stay engaged with Profound Research as we continue to spotlight those who shape the future of science and healthcare. We eagerly anticipate sharing more visionary leaders in our upcoming editions of the Profound Research Spotlight Series.

February 8, 2024

Profound Research Charts Exciting Growth Path with Hire of CEO and Strategic Promotions of Key Leadership Roles

Nashville, TN - [February 8, 2024] - Profound Research, a leading clinical trial site network, today announced key leadership appointments aimed at driving innovation and continuing growth. These appointments include Lora Parahovnik, Ph.D., MBA, as Chief Executive Officer, along with the internal promotions of Marty Anderson to Chief Operations Officer and Christopher Church to Chief Commercial Officer.

Dr. Parahovnik brings extensive experience to her new role. She most recently served as CEO at Accel Research Sites Network where her teams set industry benchmarks for patient-centric clinical research within modern healthcare ecosystems. 

“I am honored to join an organization with a vision deeply rooted in improving patient lives, ensuring access to innovative treatments, and propelling scientific and medical progress,” said Parahovnik.  “It is a privilege to lead a team whose mission aligns seamlessly with my own values and aspirations.” 

Marty Anderson, promoted to Chief Operations Officer, has been a pivotal figure in Profound's journey, spearheading operations since the company's inception. Her 30-year experience in the clinical trial industry and dedication to operational excellence position Profound for continued growth in both quality and market presence. 

Christopher Church, promoted to Chief Commercial Officer, brings a wealth of experience in building successful commercial teams and driving business development initiatives within the clinical trial industry. His strategic leadership has been focal in expanding Profound's therapeutic area expansion and driving revenue growth. 

Dr. Jonathan Feldstein, President and co-founder of Profound Research, expressed his enthusiasm for these appointments, saying, "We are thrilled to welcome Lora Parahovnik as our CEO and to announce the well-deserved promotions of Marty Anderson and Christopher Church. Their combined ability and leadership will be instrumental in driving Profound Research forward as an industry leader dedicated to medical innovation and patient access to those treatments.”  

About Profound Research

Profound Research is an integrated clinical research network comprising trial sites embedded into independent physician practices. With a mission to expand access to clinical research for community patients and offer more therapeutic options to community physicians, Profound Research operates across Southern California, the Detroit metropolitan area, and is expanding nationwide. The company boasts a team of experienced research professionals dedicated to providing high-quality clinical research support to physicians and their patients. 

For inquiries, please contact:

info@profoundresearch.io 

Profound Research LLC 

Profound Research LLC, 1213 5th Avenue North, Nashville, TN 37208